- Phys.org reported on research recently published in an article in Nature Chemical Biology on work by a collaborative team of scientists from MSKCC, the Broad Institute, Brigham and Women’s Hospital, Dana-Farber Cancer Institute, and Massachusetts General Hospital, that outlines how they built a new cell culture model that mimics AML in its niche in the bone marrow and makes the search for promising new drugs more effective.
- PMLive reported that the non-profit Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) will bring together scientists from MSKCC, Rockefeller University and Weill Cornell Medical College and will focus on basic research and early-stage drug discovery up to the ‘proof-of-concept’ stage.
- The Wall Street Journal announced that MSKCC has placed Gelclair(R) on its formulary as the exclusive therapeutic to treat oral mucositis (OM).
MSK Library Blog
Sharing Research, Resources & News
Posts are written by library staff and reflect their personal opinions not necessarily those of MSK.
